PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Jun-2022 Nucleai to Publish Pathology-based Data at ASCO 2022 for Phase 2 Research of the Most Common Type of Non-Hodgkin’s Lymphoma Businesswire
04-Jun-2022 Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting Businesswire
04-Jun-2022 Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma Businesswire
04-Jun-2022 Atara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expanded Access Program (EAP) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and Update on Tab-cel EMA Regulatory Progress Businesswire
04-Jun-2022 ABBVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Jun-2022 Cybin Announces Additional Adelia Milestone Achievements Businesswire
03-Jun-2022 Bristol Myers Squibb Withdraws Supplemental Biologics License Application (sBLA) for Reblozyl® (luspatercept-aamt) for Non-transfusion Dependent (NTD) Beta Thalassemia Businesswire
03-Jun-2022 United Therapeutics Corporation to Present at the Jefferies Healthcare Conference Businesswire
03-Jun-2022 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
03-Jun-2022 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire
03-Jun-2022 Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Businesswire
03-Jun-2022 ADCETRIS® (brentuximab vedotin) Plus Standard of Care Chemotherapy Demonstrates Superior Event-Free Survival (EFS) vs. Standard of Care Alone in Children and Young Adults with Previously Untreated High-Risk Hodgkin Lymphoma Businesswire
03-Jun-2022 Baron & Budd Obtains Largest Asbestos Related Judgment in Louisiana Businesswire
03-Jun-2022 Call for Presentations Open for the 2022 DeviceTalks West Conference & Expo Businesswire
03-Jun-2022 Daiwa Health Development to Present Top Products at Webinar Businesswire
03-Jun-2022 EUROAPI launches its first global employee share plan “EUROAPI Action 2022” Businesswire
03-Jun-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of Investors Businesswire
03-Jun-2022 GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22 Businesswire
03-Jun-2022 Cumene Global Market Report 2022 Featuring Major Players - Royal Dutch Shell, Exxon Mobil, BP, Sumitomo Chemical, BASF, Dow Chemical, China Petroleum and Chemical Corporation, Ineos, and CEPSA - ResearchAndMarkets.com Businesswire
03-Jun-2022 PartsSource Unveils New Visual Formulary Controls and Supply Chain Risk Monitor to Help Clients Improve Equipment Uptime and Supply Chain Resiliency Businesswire